Lewy body cortical involvement may not always predict dementia in Parkinson's disease

Colosimo, C.; Hughes, A.J.; Kilford, L.; Lees, A.J.
July 2003
Journal of Neurology, Neurosurgery & Psychiatry;Jul2003, Vol. 74 Issue 7, p852
Academic Journal
Background: The presence of Lewy bodies (LB) in the neocortex and limbic system in patients with Parkinson's disease (PD) is commonly thought to be linked with cognitive impairment. The authors present here a series of patients with diagnosis of PD in life and no significant cognitive impairment who, at necropsy, satisfied the current neuropathological criteria for dementia with Lewy bodies (DLB). Methods: Two hundred and seventy six brains with PD pathology were examined at the Queen Square Brain Bank in London between 1993 and 1999. The neuropathological diagnosis was PD, but 117 patients also had sufficient LB involvement above the brain stem to satisfy the current neuropathological criteria for DLB (50 patients had a neuropathological picture consistent with the limbic category of DLB and 67 with neocortical DLB). Forty eight cases were excluded who developed early cognitive impairment together with motor features of parkinsonism, 12 cases for lack of detailed clinical history, and 19 cases with coexistent features of advanced Alzheimer's disease changes. Thirty eight patients (13.8% of the total with PD pathology and 32.5 % of the total with DLB pathology) were found where there was no or very late cognitive impairment reported in the clinical records. Results: Selected cases were 24 men and 14 women, with a mean (SD) age at onset of parkinsonian symptoms of 60.1 (10.1) years and a mean disease duration of 15.3 (5.5) years. At some time during the evolution of the disease 21 patients developed different degrees of cognitive impairment (after a mean disease duration of 12.2 (4.8) years). Clinical diagnosis at death was PD in 10 cases and PD with dementia in 11. In the remaining 17 patients no history of cognitive impairment was ever recorded in life and all of them had a clinical diagnosis of PD at death; in this subgroup, nine patients later revealed a neuropathological picture consistent with limbic (or transitional) category of DLB and eight with...


Related Articles

  • Recent Knowledge on Molecular Components of Lewy Bodies Discloses Future Therapeutic Strategies in Parkinson's Disease. F. Fornai; P. Lenzi; M. Gesi; M. Ferrucci; G. Lazzeri; G. Natale; S. Ruggieri; A. Paparelli // Current Drug Targets - CNS & Neurological Disorders;Jun2003, Vol. 2 Issue 3, p149 

    Lewy bodies (LB) were first described by Lewy in 1912 [1] as neuronal pale eosinophilic inclusions which became a pathological hallmark of Parkinson's disease (PD). In his original study, Lewy defined these inclusions as pale eosinophilic cytoplasmic structures, and studies since then have...

  • Neurology and Psychiatry: Parkinson's Disease.  // Current Medical Literature: Health Care of Older People;2003, Vol. 16 Issue 2, p39 

    Analyzes whether Parkinson's disease with dementia and dementia with Lewy bodies (DLB) are two separate entities or the same condition at different positions along the spectrum of diseases associated with Lewy bodies. Autopsy of patients who had Lewy body disease; Clinical features of DLB;...

  • Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mezey, E.; Dehejia, A.M.; Harta, G.; Suchy, S.F.; Nussbaum, R.L.; Brownstein, M.J.; Polymeropoulos, M.H. // Molecular Psychiatry;1998, Vol. 3 Issue 6, p493 

    A missense mutation in the human alpha synuclein gene was recently identified in some cases of familial Parkinson's disease (FPD). We have developed an antibody that recognizes the Cterminal 12 amino acids of the human alpha synuclein protein and have demonstrated that alpha synuclein is an...

  • Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease. Ransmayr, Gerhard; Seppi, Klaus; Donnemiller, Eveline; Luginger, Elisabeth; Marksteiner, Josef; Riccabona, Georg; Poewe, Werner; Wenning, Gregor K. // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 10, p1523 

    The aim of this study was to compare parkinsonian features and loss of striatal dopamine transporter (DAT) function in patients with dementia with Lewy bodies (DLB) and Parkinson's disease (PD), matched for age and disease duration. Twenty patients with DLB, 24 PD patients and 10 matched...

  • Diagnosing dementia with Lewy bodies. Walker, Z.; Walker, R.W.H. // Current Medical Literature: Parkinson's Disease;2003, Vol. 5 Issue 1, p1 

    Provides information on dementia with Lewy bodies. Clinical diagnostic criteria; Pattern of cognitive deficit; Parkinsonian features.

  • Dementia with Lewy Bodies: Clinical Features and Treatment. Campbell, S.; Stephens, S.; Ballard, C. // Drugs & Aging;2001, Vol. 18 Issue 6, p397 

    Dementia with Lewy bodies (DLB) accounts for 15 to 20% of late-onset dementias. The overlap of cognitive symptoms, neuropsychiatric features, parkinsonism and severe sensitivity to antipsychotic drugs raise a number of key management issues. The neurochemical profile of DLB provides a good...

  • Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients. Jamrozik, Zygmunt; Lugowska, Agnieszka; Slawek, Jaroslaw; Kwiecinski, Hubert // Journal of Neurology;Mar2010, Vol. 257 Issue 3, p459 

    A letter to the editor is presented about the association of glucocerebrosidase mutations with Parkinson's disease and dementia with Lewy bodies.

  • Parkinson's Disease Dementia. Robottom, Bradley J.; Weiner, William J. // Current Psychiatry Reviews;2009, Vol. 5 Issue 3, p218 

    Parkinson's disease (PD) is the second most common neurodegenerative illness diagnosed in the United States. Dementia is recognized to be common in PD, occurring in 19-78% of patients depending upon the definition used. The cognitive syndrome of Parkinson's disease dementia is predominantly one...

  • Dementia with Lewy bodies: Enigmatic presentation. Al-Harrasi, Ahmed; Aravazhi, M. Shanmugapriya; Al-Sinawi, Hamed // International Journal of Nutrition, Pharmacology, Neurological D;Feb2013, Vol. 3 Issue 2, p156 

    Illness may present clinically in different ways causing misdiagnosis of the case and inappropriate treatment; an example of this is dementia with Lewy bodies. This neurodegenerative disorder has overlapping features with both Alzheimer's disease and Parkinson's disease dementia, which tends to...


Read the Article


Sign out of this library

Other Topics